30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study

30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study

Abstract Background Enterobacteriaceae are common pathogens in pneumonia, sepsis and urinary tract infection (UTI). Though rare, carbapenem resistance (CRE) among these organisms complicates efforts to ensure adequate empiric antimicrobial therapy. In turn this negatively impacts such outcomes as mo...

Full description

Bibliographic Details
Main Authors: Marya D. Zilberberg, Brian H. Nathanson, Kate Sulham, Weihong Fan, Andrew F. Shorr
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Antimicrobial Resistance and Infection Control
Subjects:
Enterobacteriaceae
Costs
Readmission
Sepsis
Pneumonia
UTI
Online Access:http://link.springer.com/article/10.1186/s13756-017-0286-9

Internet

http://link.springer.com/article/10.1186/s13756-017-0286-9

Similar Items